OSAP Joins Forces With JCDA Oasis ANNAPOLIS, MD — MAY 15, 2013 — The Organization for Safety, Asepsis and Prevention (OSAP) is joining forces with the Canadian Dental Association and its Journal of the Canadian Dental Association Oasis program to bring infection prevention resources to Canadian dental professionals. Recently, the JCDA underwent a […]
This Medical Condition is presented by the JCDA Oasis Team and is available on Oasis Help Definition Stroke (cerebrovascular accident) is a serious and often fatal neurologic event characterized by the rapid appearance (usually over minutes) of a focal deficit of brain function. Pathophysiology: Of patients presenting with a stroke, 85% will have sustained a […]
This Post is adapted from the Canadian Pharmacists Association (CPhA) Drug Monograph: Calcium Channel Blockers Indications Angina Arrhythmias Hypertension Migraine prophylaxis: Verapamil Muscle cramps: Diltiazem Product Summary Pharmacology This monograph focuses on the calcium channel blockers (CCBs) affecting the cardiovascular system. CCBs (also referred to as slow channel blockers, calcium entry blockers or calcium antagonists) are […]
This Systematic Review Summary is adapted from the British Evidence-Based Dentistry Journal Full Text (html) Full Text (PDF) Clinical Question Does endodontic microsurgery (EMS) have better outcomes than contemporary root-end surgery (CRS)? Main Results Fourteen studies met the inclusion criteria. Weighted pooled success rates calculated from extracted raw data showed an 88% positive outcome for […]
This post is an adaptation of the Extrusion article found in the Dental Trauma Guide Extrusion Partial displacement of the tooth out of its socket An injury to the tooth characterized by partial or total separation of the periodontal ligament resulting in loosening and displacement of the tooth. The alveolar socket bone is intact in […]
This summary is based on comprehensive Optimal Therapy Reports on the topic prepared by Canadian Agency for Drugs and Technologies in Health (CADTH): Second- and Third-Line Therapy for Patients with Type 2 Diabetes Report Summary (PDF) Full Report (PDF) The Canadian Agency for Drugs and Technologies in Health (CADTH) has released a series of Optimal Therapy Reports on the […]
This Post is adapted from the Canadian Pharmacists Association (CPhA) Drug Monograph: Benzodiazepines Benzodiazepines Product Summary Information Indications Contraindications Patients with known hypersensitivity to this class of drugs or to any component of the product in question. Patients with myasthenia gravis and acute angle-closure glaucoma, but they may be used in patients receiving […]
This Post is adapted from the Canadian Pharmacists Association (CPhA) Drug Monograph: Biphosphonates Product Summary Pharmacology Bisphosphonates (previously called diphosphonates) are stable analogues of pyrophosphate. After binding to bone surfaces, they slow the formation of hydroxyapatite crystals and delay their aggregation into large clusters. They also interfere with the resorptive action and promote apoptosis (programmed […]